RotaTeq

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Two live-attenuated rotavirus group A (RVA) vaccines, Rotarix (G1P[8]) and RotaTeq (G1-G4, P[8]), have been successfully… (More)
Is this relevant?
2012
2012
BACKGROUND RotaTeq vaccine was introduced into the Australian National Immunisation Program in 2007. This study identified and… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2011
Highly Cited
2011
BACKGROUND Rotavirus vaccines, RotaTeq and Rotarix, were introduced into the Australian National Immunization Program on July 1… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
Review
2010
Review
2010
BACKGROUND Rotavirus results in higher diarrhoea-related death in children less than five years of age than any other single… (More)
Is this relevant?
2010
2010
Although rotavirus vaccines are known to be shed in stools, transmission of vaccine-derived virus to unvaccinated contacts… (More)
Is this relevant?
2010
2010
RotaTeq is a pentavalent rotavirus vaccine that contains five human-bovine reassortant strains (designated G1, G2, G3, G4, and P1… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 4
Is this relevant?
2010
2010
Phase III studies of an oral, live, pentavalent, human-bovine reassortant rotavirus vaccine (RotaTeq; Merck) in developed… (More)
Is this relevant?
2009
2009
A pentavalent human-bovine reassortant oral rotavirus vaccine, RotaTeq, was evaluated among nearly 70,000 infants in the… (More)
Is this relevant?
2008
2008
BACKGROUND In 1999, a previous rotavirus vaccine (RotaShield; Wyeth Laboratories, Marietta, PA) was withdrawn from the US market… (More)
Is this relevant?
Review
2008
Review
2008
Rotavirus (RV) is a leading cause of diarrhea worldwide, and will infect every child by their 5th birthday. The 3-dose oral… (More)
Is this relevant?